Process Improvement: Investigator Payments


Copyright: This PDF purchase is for a Single user for review or filing purposes only. The PDF is watermarked. If you are interested in a PDF reprint to post on your website or distribute electronically, or hard-copy reprints, please contact Marah Walsh at

SKU: 1510. Category: .

Product Description

Sites are charged with managing a host of interconnected components — everything from patient recruitment and retention to data capture. Yet, often the business end of the investigative business is an afterthought, which unfortunately, can have a negative impact on how a site performs its assigned functions.
“Sites put a lot of effort into managing protocols but unfortunately many have difficulty knowing what their true costs are for their services,” says Chris Cabell, M.D., senior VP, access to patients, at Quintiles Transnational. “Therefore, throughout the industry, it’s difficult to assess whether payments are reasonable or unreasonable because most sites don’t capture their costs very efficiently.”
Experts in the field note that cost transparency is an important consideration because of the increasing complexity of protocols.

Site Perspectives on Conducting Research

Experts on this topic
Chris Cabell, M.D. Senior VP, Access to Patients, Quintiles Transnational Corp., which provides drug development,
strategic partnering, and commercialization services. For more information, visit, or e-mail
Todd Esporas. Senior Director of Contracts and Functional Services, INC Research, which is a therapeutically focused contract research organization. For more information, visit
William E. Gannon, Jr., M.D. Chief Scientific Officer and Medical Director, Capital City Technical Consulting,
which specializes in medical consulting services and international and domestic solutions. For more information, visit
Robert Robbins. President, Pinnacle Trials Inc., which is a multi-specialty site network for clinical research. For more information, visit, or e-mail
Lori Shields. VP of Operations for Trial Planning, Medidata, which is a global provider of electronic clinical data capture,
management and reporting solutions. For more information, visit, or e-mail
Gary Tyson. Senior VP and Head of Clinical Development Practice, Campbell Alliance, which is a management consulting firm specializing in the pharmaceutical and biotech industries. For more information, visit
Samuel Whitaker. CEO, GreenPhire Inc., which is a communication and payment specialist that combines electronic
communication tools with prepaid debit card technology. For more information, visit, or e-mail